Assaying Susceptibility of Avian and Other Influenza A Viruses to Zanamivir: Comparison of Fluorescent and Chemiluminescent Neuraminidase Assays
- 1 September 2003
- journal article
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 47 (s3) , 1141-1144
- https://doi.org/10.1637/0005-2086-47.s3.1141
Abstract
Zanamivir has been shown to inhibit both human and avian influenza viral neuraminidases (NAs) and has been approved in several countries for the treatment and prophylaxis of influenza infection. Reliable monitoring of drug resistance is important for assessment of the impact of drug therapy on circulating virus populations. This study compares the current fluorometric (FL) method for evaluating zanamivir susceptibility with a recently developed chemiluminescent (CL) NA activity assay using viruses representative of all nine NA subtypes. The CL assay displayed signal/noise ratios that are 50–100 times greater than those associated with the FL assay. Human H3N2 strains appeared to exhibit greater NA activity relative to avian subtypes with the FL substrate but not with the CL substrate. Additionally, the CL assay remained linear over three orders of magnitude compared to only one order of magnitude for the FL assay. Four of the nine NA subtypes tested in this study displayed slightly higher inhibit... Resumen Determinación de la susceptibilidad de los virus de influenza aviar y otros virus de influenza tipo A al zanamivir: comparación de las pruebas de neuraminidasa de quemiluminiscencia y fluorescencia. Se ha demostrado que el zanamivir es capaz de inhibir la neuraminidasa de los virus de influenza aviares y humanos y su uso ha sido aprobado en varios países para el tratamiento y profilaxis de la infección por influenza. Es importante la implementación de mecanismos de vigilancia para la detección de cepas resistente a la droga y el impacto de las mismas en la población de virus circulantes. Este estudio compara el método de fluorometría (FL), usado actualmente para evaluar la susceptibilidad al zanamivir, con un nuevo método basado en quemiluminiscencia (CL) para la detección de la actividad de la neuraminidasa, mediante el uso de muestras de virus representativas de los 9 serotipos de neuraminidasa. La prueba de CL mostró rangos de señal/ruido 50–100 veces mayores que los obtenidos mediante la prueb...Keywords
This publication has 10 references indexed in Scilit:
- Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assayAntiviral Research, 2001
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- Resistance of influenza viruses to neuraminidase inhibitors — a reviewAntiviral Research, 2000
- Development of a Sensitive Chemiluminescent Neuraminidase Assay for the Determination of Influenza Virus Susceptibility to ZanamivirAnalytical Biochemistry, 2000
- Influenza virus neuraminidase inhibitorsThe Lancet, 2000
- Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy StudiesAntimicrobial Agents and Chemotherapy, 2000
- Low Incidence of Rimantadine Resistance in Field Isolates of Influenza A VirusesThe Journal of Infectious Diseases, 1999
- Recovery of drug-resistant influenza A virus during therapeutic use of rimantadineAntimicrobial Agents and Chemotherapy, 1991
- Plaque inhibition assay for drug susceptibility testing of influenza virusesAntimicrobial Agents and Chemotherapy, 1980
- Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrateAnalytical Biochemistry, 1979